SOUTH PLAINFIELD, N.J., Sept. 27, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. PTCT today announced that management will present a company update at the following conferences:
Cantor Global Healthcare Conference
Friday, October 4th at 10:40 a.m. ET
Chardan Genetic Medicines Conference
Monday, October 7th at 9:00 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation is available at the same website location.
About PTC Therapeutics, Inc.
PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
FOR MORE INFORMATION PLEASE CONTACT: | |
Media: | Investors: |
Jane Baj | Emily Hill |
+1 (908) 912-9167 | +1 (908) 912-9327 |
View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-300923227.html
SOURCE PTC Therapeutics, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.